WCLC Insights into ESMO Signals: Webinar
Executive Summary: ONCrg analysts Kristen Cordova and Amber Mineo walk through the highest-impact lung cancer presentations from WCLC 2026 and preview what to watch at ESMO 2026 across small cell and non-small cell lung cancer, covering the context of each readout, how the treatment landscape is expected to shift, and the key questions the analyst team will be chasing.
- NSCLC
- ESMO 2026
- KRAS
- Oncology
- Lung Cancer
- SCLC
- Cancer Research
- Pharma CI
- Video Event
- ADCs
- WCLC 2026
- HER2
- B7-H3
- ADC targets
- zipalertinib
- Phase 3
- HER2-mutant
- T-DXd
- chemo
- LBA3
- +17
